Article Text

PDF
Coexistence of mutations in PINK1 and mitochondrial DNA in early onset parkinsonism
  1. C Piccoli1,
  2. M Ripoli1,
  3. G Quarato1,
  4. R Scrima1,
  5. A D’Aprile1,
  6. D Boffoli1,
  7. M Margaglione1,
  8. C Criscuolo2,
  9. G De Michele2,
  10. A Sardanelli3,
  11. S Papa3,4,
  12. N Capitanio1
  1. 1
    Department of Biomedical Sciences, University of Foggia, Foggia, Italy
  2. 2
    Department of Neurological Sciences, Federico II University, Naples, Italy
  3. 3
    Department of Medical Biochemistry, Biology and Physics, University of Bari, Bari, Italy
  4. 4
    Institute of Bioenergetics and Biomembranes, CNR, Bari, Italy
  1. Professor N Capitanio, Department of Biomedical Sciences, University of Foggia, via L. Pinto 1 OO.RR. 71100 Foggia, Italy; n.cap{at}unifg.it

Abstract

Aims and background: Various genes have been identified for monogenic disorders resembling Parkinson’s disease. The products of some of these genes are associated with mitochondria and have been implicated in cellular protection against oxidative damage. In the present study we analysed fibroblasts from a patient carrying the homozygous mutation p.W437X in the PTEN-induced kinase 1 (PINK1), which manifested a very early onset parkinsonism.

Results: Patient’s fibroblasts did not show variation in the mtDNA copy number or in the expression of the oxidative phosphorylation complexes. Sequence analysis of the patient’s mtDNA presented two new missense mutations in the ND5 (m.12397A>G, p.T21A) and ND6 (m. 14319T>C, p.N119D) genes coding for two subunits of complex I. The two mutations were homoplasmic in both the patient and the patient’s mother. Patient’s fibroblasts resulted in enhanced constitutive production of the superoxide anion radical that was abrogated by inhibitor of the complex I. Moreover enzyme kinetic analysis of the NADH:ubiquinone oxidoreductase showed changes in the substrates affinity.

Conclusion: To our knowledge, this is the first report showing co-segregation of a Parkinson’s disease related nuclear gene mutation with mtDNA mutation(s). Our observation might shed light on the clinical heterogeneity of the hereditary cases of Parkinson’s disease, highlighting the hitherto unappreciated impact of coexisting mtDNA mutations in determining the development and the clinical course of the disease.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Patient consent: Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.